In this episode, hosts Drs. Peter Lu and Jason Silverman talk to Dr. Rima Fawaz about the role of GLP-1 receptor agonists in the treatment of children and adolescents with metabolic dysfunction-associated steatotic liver disease or MASLD (the artist formerly known as non-alcoholic fatty liver disease or NAFLD). We discuss what these medications do, what we know about their positive and negative effects, and how we should be using them based on the current literature. Dr. Fawaz is Medical Director of Pediatric Hepatology and Liver Transplantation at Yale New Haven Children's Hospital and Associate Professor at Yale School of Medicine.

For Canadian listeners:

Please note that all listed Bowel Sounds episodes are peer-reviewed and that listening to episodes is considered a Section Two Scanning Activity by the Royal College of Physicians and Surgeons of Canada Maintenance of Certification program. Each episode is valued at 0.5 Section Two Credits. Content is valid on the date recorded but recommendations may change over time. You can document your listening and obtain your CME credits at https://mainport.royalcollege.ca